Novel Prediction of Five-Year Survival and Recurrence Rates and Discovery of Cancer Genetic Biomarkers Using MIBI Scans in the Tumor-Immune Microenvironment
ISEF · 2022 Translational Medical Science Fourth Award
Overview
Colorectal cancer (CRC) is responsible for 864,989 deaths annually, making it the second leading cause of cancer death worldwide. The leading upstream cause of cancer deaths is a lack of clinically approved biomarkers, causing inaccurate five-year survival and recurrence predictions for patient risk stratification and treatment management. Thus, my project presents a low-cost, noninvasive computational platform to predict the survival and recurrence rates of cancer patients one year in advance using newly identified biomarkers in the tumor-immune microenvironment (TIME). The first step is to preprocess the ~76k multiplexed ion beam imaging (MIBI) scans of TIME and train a 54-layer MobileNetV2 model to recognize cancerous tissue, profile cell-to-cell interactions and protein patterns, and establish links between the spatial organization of cells with varying expression patterns. By translating this information, the model generates a dataset of transformed biomarkers, which is leveraged to train the Cox Proportional Hazards Model. The neural network simultaneously evaluates the effect of prognostic factors on survival and predicts a rate for each patient. The identification and diagnosis models achieved AUROCs of 0.93 and 0.98 respectively, successfully exceeding all incumbent clinical techniques. This technique can be generalized to other cancer types and diseases and will lead to better clinical outcomes and spare patients from unnecessary aggressive therapies. Ultimately, this platform helps solve one of precision medicine’s primary limitations and is a pragmatic tool with industrial viability that offers clinicians the ability to leverage its personalized predictions to amplify diagnostic accuracy, determine robust treatments earlier, and save millions of lives.
Awards (1)
- Fourth Award of $500 $500
Competition history
- ISEF 2022
Resources
Related projects
ISEF · 2021
A Novel Machine Learning Based Identification Tool (ELECT) for Early Colorectal Cancer Detection through Advanced Microbiome Composition Analysis
ISEF · 2024
Enabling Scalable Precision Medicine With STAD: A Novel Computational Platform for Early Recurrence-Free Survival Prediction and Biomarker Discovery in Digital Pathology for Gastrointestinal Cancer Patients
ISEF · 2025
OncoNote: Enabling the Discovery of a Novel Digital Biomarker for Early Pan-Cancer Survival and Recurrence Prediction via Free-Text Clinical Narratives
ISEF · 2025
Colorectal Cancer Imaging and Classification - A Deep Learning Approach to Classify Histopathological Images
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair